Liewen, Heike <br/><br/>
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX).  [electronic resource] 

 -  Targeted oncology  10 2019 
 - 577-590 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1776-260X 
<br/><br/><label>Standard No.: </label>10.1007/s11523-019-00667-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Colorectal Neoplasms--drug therapy<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Engineering<br/>HCT116 Cells<br/>Heterografts<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Immunotherapy--methods<br/>Lung Neoplasms--drug therapy<br/>Membrane Proteins--genetics<br/>Mice<br/>Molecular Targeted Therapy